Rationale and Design of a Registry in a Referral and Educational Medical Center in Tehran, Iran: Sina Hospital Covid-19 Registry (SHCo-19R) by Talebpour, Mohammad et al.
ADVANCED JOURNAL OF EMERGENCY MEDICINE. 2020;4(2s):e53 Talebpour et al 
   
 
1 Copyright © 2020 Tehran University of Medical Sciences  This open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 License (CC BY-NC 4.0). 
 
Brief Report DOI: 10.22114/ajem.v0i0.361 
Rationale and Design of a Registry in a Referral and Educational Medical 
Center in Tehran, Iran: Sina Hospital Covid-19 Registry (SHCo-19R) 
  
Mohammad Talebpour1, Azar Hadadi2, Alireza Oraii3, Haleh Ashraf 4* 
 
1. Department of Surgery, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran. 
2. Department of Infectious Diseases, Sina hospital, Tehran University of Medical Sciences, Tehran, Iran. 
3. Students’ Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran. 
4. Research Development Center, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran. 
 
*Corresponding author: Haleh Ashraf; Email: hashraf@sina.tums.ac.ir 
Published online: 2020-03-22 
Abstract  
Coronavirus disease 2019 (Covid-19) is caused by the novel coronavirus resulting in a highly contagious 
respiratory tract infection with an increased risk of acute respiratory distress syndrome (ARDS), which was 
first seen in Wuhan, China. Thus far, this virus has spread to many countries worldwide, including Iran. 
Multiple studies have assessed disease characteristics, viral genetics, and complications of Covid-19 in the 
Chinese population. However, there is limited data regarding patient characteristics and outcomes of infected 
cases outside of China. Besides, risk factors of adverse outcomes are poorly identified in different populations. 
Due to limited data in the Iranian population affected by the virus, we aimed to design a registry of patients 
with Covid-19 at Sina Hospital in Tehran, Iran [Sina Hospital Covid-19 Registry (SHCo-19R)] in this regard, to 
assess patient characteristics, imaging features, laboratory findings, management strategies, and adverse 
outcomes of Iranian patients with Covid-19 and their differences with other populations. 
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INTRODUCTION
In December 2019, several cases of pneumonia of 
unknown cause with subsequent acute respiratory 
distress syndrome (ARDS) first emerged in Wuhan, 
China (1). A novel coronavirus was then identified to 
be the cause and was later named severe acute 
respiratory syndrome coronavirus 2 (SARS-CoV-2) 
by the World Health Organization (WHO) and the 
disease caused by it was called Covid-19 (2). Thus 
far, the virus has spread to many countries. 
Multiple studies from China have shown that the 
new virus is highly contagious. Covid-19 is most 
commonly reported to present with fever, dry 
cough and myalgia (3). Besides, it was shown that 
patients might develop dyspnea within one week of 
presentation with rapid deterioration of 
respiratory and end-organ failure (4).  
There are limited data from infected regions other 
than china and there is an urgent need to identify 
specific patient characteristics and outcomes in 
different populations. Unfortunately, Iran is 
amongst the top countries with the highest number 
of cases outside China struggling to provide care 
for a large pool of patients with Covid-19. On this 
occasion, it is of utmost importance to implement 
high-quality researches on Covid-19 for better 
prevention, diagnosis, and treatment. Hence, we 
decided to start a registry of patients with Covid-19 
at Sina hospital [Sina Hospital Covid-19 Registry 
(SHCo-19R)], which is one of the designated 
referral centers for COVID-19 cases in Tehran, the 
capital of Iran. We are registering clinical 
presentations, diagnostic workups, treatments, 
hospital course, and follow-up of our patients. We 
are going to report descriptive and analytic results 
soon; we believe that publishing this report 
enables us to receive comments from experts in the 
field from all over the world. Moreover, it can be a 
starting point for international collaborations on 
this topic. 
Methods 
Study design and setting 
Sina Hospital Covid-19 Registry is an ongoing, 
prospective, hospital-based registry of patients 
diagnosed with Covid-19 presenting to emergency 
department (ED) of Sina Hospital, affiliated to 
Tehran University of Medical Sciences (TUMS). 
This study commenced patient enrollment in 
February 2020 after Sina hospital was declared a 
Covid-19 referral center in south Tehran. Enrolled 
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patients are followed during the hospitalization 
period and for one month after discharge. This 
registry is designed in compliance with the 
reporting standards of STROBE guidelines and in 
accordance with the Declaration of Helsinki 
Principles in term of all interventions (5, 6). This 
project is approved by the Covid-19 research 
committee of Sina hospital and the ethical 
committee of TUMS.  
Patients and data collection 
Patients over 18 years of age with suggestive 
symptoms of Covid-19 infection (e.g. fever, cough, 
dyspnea) accompanied by chest computed 
tomography (CT) scan findings compatible with 
COVID-19 or definite diagnosis of Covid-19 with 
real-time polymerase chain reaction (RT-
PCR)  have been included (7, 8). Data regarding 
demographic features, prehospital findings, chest 
CT scan findings, laboratory data, hospitalization 
and/or intensive care units (ICU) course, in-
hospital outcomes, follow-up events, and 
complications are recorded on separate 
predesigned checklists or a web-based electronic 
report form by trained staff members.  
After patient discharge or death, data from patient 
files and checklists are retrieved and entered into a 
specifically designed web-based electronic report 
form by trained nurses, physicians and 
researchers. After discharge, patients or 
designated family members are contacted 
alternately through telephone calls to assess the 
vital status, readmission and drug complications 
for one month.  
Measures and outcomes 
Figure 1 depicts the comprehensive algorithm of 
patient care for individuals presenting with 
 
Figure 1: Algorithm of patient care for individuals presenting with respiratory symptoms to Sina hospital emergency department  
RR: Respiratory rate; SpO2: Oxygen saturation; CT: computed tomography 
* Fever: temperature ≥37.3 in the morning and ≥37.7 in the evening  
** High-risk group: immunocompromised patients (chemotherapy, malignancy, organ transplant, corticosteroid use, HIV), 
cardiovascular disease, hypertension, diabetes, chronic respiratory disease, pregnancy, body mass index≥40, age more than 50 years, 
chronic kidney disease, cirrhosis 
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respiratory symptoms in to the ED after the 
outbreak of Covid-19. Patients diagnosed with 
Covid-19 are treated according to the latest 
national guidelines as these protocols are subject 
to change and are constantly being updated based 
on emerging new evidence. All patients with 
possible diagnosis of Covid-19 undergo a chest CT 
scan and laboratory testing for complete blood 
count with differential, C-reactive protein (CRP), 
serum creatinine, sodium, potassium, magnesium, 
vitamin D, liver function tests, troponin, ferritin, 
and blood group.  
Further investigations are performed based on a 
predesigned protocol and at the discretion of 
attending physicians (Table 1). During 
hospitalization, patients are monitored for blood 
pressure, fever, respiratory symptoms, oxygen 
saturation, serum electrolytes, and drug 
complications, as well as adverse outcomes such as 
death, respiratory complications (such as ARDS 
and superimposed bacterial infections), cardiac 
complications (such as myocarditis, acute coronary 
syndrome, and arrhythmia) and renal 
complications (such as oliguria and decreased 
serum creatinine). 
Bias and Quality Assurance 
The retrospective nature of data retrieval from 
medical records might exert some bias on data 
entry. However, the use of predesigned Covid-19 
checklists decreases the amount of missing data 
and bias. Besides, due to the unknown nature of the 
disease, national guidelines and protocols might 
change during the study. Hence, a committee of 
physicians is constantly monitoring national 
recommendations, issues in data collection, and 
accuracy of data entry. 
Table 1: Further investigations in patients with Covid-19 
Test Findings 
All patients 
Laboratory tests Complete blood count with differential 
CRP  
Serum creatinine 
Na, K, Mg, vitamin D 




Electrocardiogram ST-T change 
Arrhythmia 
Chest CT scan Density (ground-glass opacity, consolidative opacity, mixed) 
Internal characteristics of the lesion (crazy-paving, reversed halo sign) 
Axial location, Lobar location 
Shape (patchy, round-nodular, confluent) 
Other findings (tree-in-bud opacities, predominantly nodular opacities, predominantly reticular opacities, 
cavitation, mediastinal lymphadenopathy, pleural effusion) 
If myocarditis suspected 
Laboratory tests LDH 
CPK 
Pro-BNP 
Echocardiography Ventricular dysfunction 
Pericardial effusion 
In ICU admitted patients 
Laboratory tests PT, PTT, INR 
D-dimer 
ICU course sheet APACHE score, SOFA score 
Types of Oxygen therapy (reservoir bag, CPAP, NIV, intubation) 
Oxygenation status (SPO2, PAO2/FiO2, PAO2 during and after intubation) 
Lung dynamics (compliance, resistance) 
Advanced hemodynamic parameters with USCOM 
Complications and outcomes 
If sepsis suspected 
Laboratory tests Arterial blood gas 
Procalcitonin 
Blood culture (x2) 
CPAP: Continuous positive airway pressure; CPK: Creatine kinase; CRP: C-reactive protein; CT: Computed tomography; INR: 
International normalized ratio; LDH: Lactate dehydrogenase; NIV: non-invasive ventilation; PAO2/FiO2: Arterial partial pressure of 
oxygen/ Fraction of inspired Oxygen; Pro- BNP: Pro-brain natriuretic peptide; PT: Prothrombin time; PTT: Partial thromboplastin 
time; SPO2: Oxygen saturation, USCOM: Ultrasonic Cardiac Output Monitors; ICU: intensive care unit; APACHE: Acute Physiology And 
Chronic Health Evaluation; SOFA: Sequential Organ Failure Assessment 
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DISCUSSION 
SHCo-19R is an ongoing registry of patients with 
COVID-19 in Tehran, Iran, designed to evaluate 
patient characteristics, findings and etc. In the 
study by Guan et al. on 1099 patients with 
laboratory-confirmed Covid-19, it was shown that 
five percent of patients were admitted to ICU, 2.3% 
needed intensive mechanical ventilation, and 1.4% 
died. In addition, ARDS was the most common 
complication among patients presenting with 
severe disease with a prevalence of 15.6% followed 
by septic shock (6.4%) and acute kidney injury 
(2.9%) (9). Similar studies have shown that ARDS, 
cardiac injury, secondary infection, and end-organ 
failure are among the most frequent complications 
of the disease  (3, 10). Besides, recent studies have 
proved the involvement of angiotensin-converting 
enzyme 2 in Covid-19, leading to an increased risk 
of cardiac myocyte injury (11, 12). Overall, the same 
data are limited in the Iranian population. This 
study will provide valuable epidemiological 
knowledge on Iranian patients with Covid-19. 
These findings will be used to 1) identify patient 
characteristics, comorbidities, and previous risk 
factors; 2) evaluate outcome in these patients and 
a better understanding of risk factors associated 
with adverse events; 3) assess changes in 
laboratory findings of Covid-19 cases and their 
association with poor outcomes; 4) evaluate 
different treatment strategies and their potential 
efficacy and safety and 5) form a base for 
conduction of future therapeutic clinical trials. 
CONCLUSIONS 
Here, in this paper, we introduced SHCo-19R which 
is an ongoing, prospective, hospital-based registry 
of patients with Covid-19 admitted to Sina hospital, 
affiliated to TUMS, in Tehran, Iran.  
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Baratloo, Alireza MD Department of Emergency Medicine 
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